Inj.teriparatide-250 mcg/ml -3 ml vial o [inj.teriparatide-250 mcg/ml -3 ml vial or pfs]

41270 - elite h5 control-normal. one vial of 3ml of each pack contains elite h5 control-normal.

41269- elite h5 control-low .each pack contains one vial of 3ml of elite h5 control-low.

Syrup iron, each 5 ml contains elemental iron(main ingredient) atleast 30 mg per 5 ml, at least 200 ml bottle

Inj. lignocaine 2 percent with adrenaline (1:80000) in 30 ml vial packing.

Inj cisatracurium 20 mg per 10ml vial of 10 ml,inj sugammadex 100 mg per ml vial of 2 ml,inj dexmedetomidin 200 mcg per 2 ml,inj intralipid 20 persent amino acid 20 persent lipid 100 ml,inj succinylcholine chloride 50 mg per ml vial of 10 ml,inj mephentermine 300 mg per 10 ml vial

Bza-drug (ph no.:12038) each 5 ml suspension contains ofloxacin 50 mg + metronidazole 100 mg- minimum of 30 ml bottle

Recombinant antigen for hepatitis-b virus vaccine (20 mcg. hepatitis b antigen ) single dose 1 ml amp./vial

1) srphc82151025-glycopyrolate 0.5 mg + neostigmine methyl sulphate 2.5 mg inj 5 ml amp, 2) srphc82151020-glycopyrrolate 0.2mg/ml inj 1 ml amp, 3) srphc82185434-glycopyrrolate 25mcg inhalation solution of 1ml respule s, 4) srphc82185450 glycopyrrolate 9 mcg, for moterol 4.8 mcg and budesonide 160 mcg inhaler, 120 mdi canister & 5) srphc82185470-indacaterol 110 mcg + glycopyrronium 50 mcg cap

1) each gram of placenta extract gel contains extract of 0.1 g of fresh human placenta 20 g tube, 2) recombinant human epidermal growth factor gel 150 mcg/ g, 7.5 g tube & 3) each ml of placenta extract is derived from 0.1 g of fresh human placenta inj 2 ml amp